According to a filing, CHINARES PHARMA (03320) has announced the results of China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd. (000999) for the first nine months of 2026.
Total operating revenue came in at approximately RMB 21.41 billion, representing a year-on-year decline of 2.62%.
Net profit stood at approximately RMB 2.601 billion, down 10.28% compared with the same period a year earlier.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments